布地奈德哮喘胶囊治疗哮喘吗

Budesonide enteric-coated capsules are a new dosage form that can be used orally, but only 10% of the drug will be absorbed into the blood system. The indications include 1. For patients with glucocorticoid-dependent or independent bronchial asthma and asthmatic chronic bronchitis. 2. Patients with mild to moderate colonic Crohn's disease and ulcerative colitis limited to the sigmoid colon can use this product for enema.

Budesonide can enhance the stability of endothelial cells, smooth muscle cells and lysosomal membranes, inhibit immune responses and reduce antibody synthesis, thereby reducing the release and activity of allergic active mediators such as histamine, and reducing the enzymatic process triggered when antigens and antibodies are combined; it can enhance the stability of endothelial cells, smooth muscle cells and lysosomal membranes, inhibit immune responses and reduce antibody synthesis, thus It can reduce the release and activity of allergic active mediators such as histamine, reduce the enzymatic process stimulated when antigens and antibodies combine, inhibit the synthesis and release of bronchoconstrictor substances, and reduce the contraction reaction of smooth muscle. Acute, subacute and long-term toxicity studies have found that the systemic effects of this product, such as weight loss, lymphoid tissue and adrenal cortex atrophy, are weaker or equivalent to other glucocorticoids.

The most common side effects of Budesonide (Budenofalk) include: 1. About 5% of patients will experience local irritation as an adverse reaction when using Budesonide. 2. Common adverse reactions of Budesonide: local irritation, slight bloody discharge, and nosebleeds. Rare side effects of Budesonide (Budenofalk). Systemic: Angioedema Skin: Urticaria, rash, dermatitis, pruritus. Airways: Nasal septal perforation and mucosal ulceration. Immediate or delayed allergic reactions including urticaria, rash, dermatitis, angioedema, and pruritus have been reported. A rare number of patients develop mucosal ulceration and septal perforation after intranasal steroid administration.